New study points to better diagnostics for cancer

Irvine, CA – January 27, 2021 – A new University of California, Irvine-led study finds a new method for identifying biomarkers may aid in early cancer diagnosis. The study focused on lung cancer, however the Cell Heterogeneity-Adjusted cLonal Methylation (CHALM) method has been tested on aging and Alzheimer’s diseases as well and is expected to be effective for studying other diseases.

“We found the CHALM method may be a valuable tool in helping researchers to identify more reliable differentially methylated genes from sequence-based methylation data,” said Wei Li, PhD, the Grace B. Bell chair and professor of bioinformatics in the Department of Biological Chemistry at the UCI School of Medicine. “For clinicians, this method may aid in cancer diagnosis by helping them identify more useful biomarkers, which are overlooked by the traditional method.”

Published in Nature Communications, the study, titled, “Cellular Heterogeneity–Adjusted cLonal Methylation (CHALM) improves prediction of gene expression,” illustrates the importance of considering cell heterogeneity when calculating the DNA methylation level from sequencing data.

“After applying our CHALM method to a lung cancer dataset, we were able to identify more reliable and biological functions-related differentially methylated genes. Applying our CHALM method may lead to better early cancer detection,” said Li.

Using traditional methods for identifying cancer biomarkers, researchers have consistently found the correlation between gene expression and promoter methylation to be weak, especially for low methylated genes. This new study found the CHALM method allowed for more reliable identification of methylated markers that cannot be detected by traditional methods.

This study was funded in part by the National Institutes of Health.

About the UCI School of Medicine

Each year, the UCI School of Medicine educates more than 400 medical students and nearly 150 PhD and MS students. More than 700 residents and fellows are trained at the UCI Medical Center and affiliated institutions. Multiple MD, PhD and MS degrees are offered. Students are encouraged to pursue an expansive range of interests and options. For medical students, there are numerous concurrent dual degree programs, including an MD/MBA, MD/MPH, or an MD/MS degree through one of three mission-based programs: the Health Education to Advance Leaders in Integrative Medicine (HEAL-IM), the Program in Medical Education for Leadership Education to Advance Diversity-African, Black and Caribbean (PRIME LEAD-ABC), and the Program in Medical Education for the Latino Community (PRIME-LC). The UCI School of Medicine is accredited by the Liaison Committee on Medical Accreditation and ranks among the top 50 nationwide for research. For more information, visit medschool.uci.edu.